NCT02119936

Brief Summary

Purpose: The investigators plan a feasibility study on an easily disseminated biofeedback tool to reduce stress among hospitalized and expecting mothers. Converging evident suggests that Heart Rate Variability Biofeedback (HRVB) can improve the threshold of stress management and improve executive functioning. Additionally HRVB has been shown to significantly reduce anxiety features in women suffering from perinatal depression. The investigators hypothesize that HRVB will reduce stress levels among expecting mothers hospitalized for pregnancy complications, who are at high risk for depression and anxiety. Participants: Expecting mothers hospitalized for pregnancy complication, who are at high risk for depression and anxiety. Procedures: The investigators plain to use a heart rate variability biofeedback tool to measure stress reduction in hospitalized expectant mothers. This tool will be coupled with validated surveys and scales, high frequency heart rate variability, saliva samples, and qualitative interviews to quantify the reduction in stress from the HRVB tool.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 16, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 22, 2014

Completed
9 days until next milestone

Study Start

First participant enrolled

May 1, 2014

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

March 19, 2018

Completed
Last Updated

March 19, 2018

Status Verified

May 1, 2017

Enrollment Period

2 years

First QC Date

April 16, 2014

Results QC Date

May 1, 2017

Last Update Submit

August 25, 2017

Conditions

Keywords

StressAnxietyMental HealthMental Health ServicesMaternal Mental Health

Outcome Measures

Primary Outcomes (1)

  • Feasibility of Using HRVB Among Hospitalized Pregnant Women

    The investigators will report rates of enrollment among women approached to join the study, rates of longitudinal data collection, and loss to follow-up.

    Baseline, in-patient follow-up (5 to 7 days after baseline), and follow-up phone call (6 to 8 weeks post in-patient follow-up)

Secondary Outcomes (5)

  • Change in State-Trait Anxiety Inventory From Baseline to In-patient Follow up (5-7 Days).

    Baseline to in-patient follow-up (5 to 7 days in between)

  • Association Between HRVB and High-Frequency Heart Rate Variability (HF-HRV)

    Baseline to in-patient follow-up (5 to 7 days in between)

  • Correlation of HRVB Feedback With Varying Levels of Clinical Depression and Anxiety

    Baseline to in-patient follow-up (5 to 7 days in between)

  • Change in Linear Analog Self-Assessment (LASA) From Baseline to In-patient Follow up (5-7 Days).

    Baseline to in-patient follow-up (5 to 7 days in between)

  • Change in Warwick Edinburgh Mental Well Being Scale From Baseline to In-patient Follow up (5-7 Days).

    Baseline to in-patient follow-up (5 to 7 days in between)

Study Arms (1)

Heart Rate Variability Biofeedback Tool

EXPERIMENTAL

Intervention: Participants will be taught how to use the Heart Rate Variability Biofeedback tool (emWave 2) as a mechanism to reduce stress and anxiety, then use the tool, coupled with deep breathing exercises, to visualize their stress reduction.

Behavioral: Heart Rate Variability Biofeedback Tool

Interventions

The Heart Rate Variability Biofeedback tool (emWave 2) will capture heart rate variability (HRV) before and after deep breathing exercises are used among participants. Participants will be able to visualize changes in their HRV and then fill-out self-reported anxiety measures to determine if the breathing exercises and visualization of HRV affected anxiety.

Also known as: emWave 2 (Heartmath)
Heart Rate Variability Biofeedback Tool

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient has signed the informed consent before any study specific procedures are performed.
  • Patient is a pregnant female over 18 years of age that is an in-patient on the UNC Women's Hospital antepartum floor.
  • Patient agrees to adhere to study requirements

You may not qualify if:

  • Does not speak English.
  • Patient is not expected be on the antepartum floor of UNC Women's Hospital for at least 7 days.
  • Patient's healthcare provider does not want the patient to participate for medical safety purposes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UNC-Chapel Hill

Chapel Hill, North Carolina, 27510, United States

Location

Related Publications (4)

  • Beckham AJ, Greene TB, Meltzer-Brody S. A pilot study of heart rate variability biofeedback therapy in the treatment of perinatal depression on a specialized perinatal psychiatry inpatient unit. Arch Womens Ment Health. 2013 Feb;16(1):59-65. doi: 10.1007/s00737-012-0318-7. Epub 2012 Nov 25.

  • Brandon AR, Trivedi MH, Hynan LS, Miltenberger PD, Labat DB, Rifkin JB, Stringer CA. Prenatal depression in women hospitalized for obstetric risk. J Clin Psychiatry. 2008 Apr;69(4):635-43. doi: 10.4088/jcp.v69n0417.

  • MacMullen N, Dulski LA, Pappalardo B. Antepartum vulnerability: stress, coping, and a patient support group. J Perinat Neonatal Nurs. 1992 Dec;6(3):15-25. doi: 10.1097/00005237-199212000-00004. No abstract available.

  • Poehlmann J, Fiese BH. The interaction of maternal and infant vulnerabilities on developing attachment relationships. Dev Psychopathol. 2001 Winter;13(1):1-11. doi: 10.1017/s0954579401001018.

MeSH Terms

Conditions

Anxiety DisordersPsychological Well-Being

Condition Hierarchy (Ancestors)

Mental DisordersPersonal SatisfactionBehavior

Results Point of Contact

Title
Holly Krohn
Organization
UNC Chapel Hill

Study Officials

  • Samantha Meltzer-Brody, MD, MPH

    UNC-Chapel Hill

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 16, 2014

First Posted

April 22, 2014

Study Start

May 1, 2014

Primary Completion

May 1, 2016

Study Completion

October 1, 2016

Last Updated

March 19, 2018

Results First Posted

March 19, 2018

Record last verified: 2017-05

Data Sharing

IPD Sharing
Will not share

Locations